Skip to main content

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-19

About This Grant

Project Summary Arthropod-borne viruses or “arboviruses” are insect-transmitted viral pathogens that pose a significant threat to human and animal health worldwide. However, we still lack effective therapeutics to combat most arbovirus infections. A deeper understanding of the conserved innate immune mechanisms that restrict arbovirus replication in insect and mammalian hosts may reveal strategies for preventing or treating arboviral disease. Thus, we sought to develop an innovative, yet simplistic, approach to identify conserved antiviral host factors affecting arbovirus replication that, at the same time, inherently provides insight into virally-encoded strategies that evade these host defenses. Here, we propose to use a novel arbovirus "rescue" assay wherein candidate immune evasion proteins (IEPs) encoded by unrelated mammalian viruses can be transiently expressed in insect cells and assayed for their ability to sensitize insect cells to arbovirus infection. The rationale behind this approach is that mammalian virus-encoded IEPs that enhance arbovirus replication in insect cells likely do so because they happen to inhibit key antiviral factors/pathways that are conserved between insect and mammalian hosts. One can then use these IEPs as “tools” to identify and characterize the conserved immunity factors these IEPs target. Thus, this screening methodology provides a mechanism to both identify novel IEPs encoded by mammalian pathogens and the functionally-relevant components of the eukaryotic innate immune response these IEPs inhibit. To discover IEPs that promote arbovirus replication in insect cells, we will screen an expression library encoding 93 “viral ubiquitination modulators (VUMs)” derived from 33 different mammalian viruses. VUMs are virally-encoded proteins that inhibit, usurp, and/or re-direct the host ubiquitination system to promote viral replication. Given that ubiquitination is a key post-translational modification that alters the stability and/or function of cellular proteins, VUMs often hijack the ubiquitination system to inhibit or degrade host proteins that are critical for antiviral defense. We hypothesize that some VUMs may target cellular antiviral factors that are conserved between insect and mammalian hosts and that are critical for restricting arboviruses. Indeed, our initial screens identified VUMs from disparate mammalian viruses that enhance arbovirus replication in insect cells. These results, along with our prior successes in using this system to identify novel IEPs and conserved antiviral responses (Rex et al., 2024, Nat. Microbiol.; Embry et al., 2024, PLoS Pathog.), suggest that we can use VUMs as tools to both inhibit, and discover, conserved antiviral immunity factors. Our study will: 1) Identify VUMs encoded by mammalian viruses that promote arbovirus replication in insect cells; 2) Identify conserved insect and mammalian factors interacting with VUM “hits” from our arbovirus rescue assays; and 3) Identify the conserved host factors interacting with VUMs that normally block arbovirus replication. Our long-term goal is to use this system to define the critical eukaryotic innate immune mechanisms that restrict arbovirus replication.

Grant Summary

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $249K for university, nonprofit, healthcare org. Applications are due 2028-03-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $249K

Deadline

2028-03-31

Complexity
Medium
  1. 1Confirm your organization is eligible for Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators: Frequently Asked Questions

Who is eligible for the Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators?

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators provide?

Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators provides up to $249K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators deadline?

Applications for Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators are due 2028-03-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators?

To apply for Identification of Ancient Antiviral Defenses Using Viral Ubiquitination Modulators, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants